In this free webinar, gain insights into aligning system designs with the FDA's 2023 cybersecurity guidelines, focusing on secure architecture, cloud integration and effective SBOMs management. Attendees will learn how to continuously monitor devices and cloud systems, and their software code, to meet the FDA guidelines. The featured speakers will discuss critical considerations like differentiating between safety and security risk management, the importance of integrated security processes, threat modeling and comprehensive cybersecurity testing.
TORONTO, Jan. 15, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar decoding The Food and Drug Administration's (FDA) 2023 guidelines about the cloud and medical device cybersecurity landscape. Medical device cybersecurity has undergone a game-changing transformation with The FDA's updated 2023 guidelines, seamlessly integrating both medical device and cloud computing aspects.
In this webinar, specifically designed for research and development (R&D), cyber and development, security and operations (DevSecOps) professionals building and maintaining medical devices, BioT, Sternum, Arnall Golden Gregory and Hogan Lovells LLP will unravel these pivotal updates. The expert panel will dissect the intricacies of the new guidelines, focusing on the dual importance of device security and cloud-based data management.
The webinar will explore key areas such as threat modeling for interconnected devices, cybersecurity risk assessment in cloud environments, interoperability considerations, management of third-party software components and the development of comprehensive Software Bills of Materials (SBOM). Key discussions will include safeguarding patient data in the cloud, ensuring secure data transmission between devices and cloud platforms and navigating the broader evolving regulatory framework for cloud-enabled medical devices.
Join this insightful webinar to be part of a forward-thinking community eager to master the future of medical device cybersecurity in the cloud era.
Join Flair Bar, Co-Founder & COO, Sternum; Alan Minsk, Partner and Lead of Food & Drug Practice Team, Arnall Golden Gregory LLP; Daniel Adler, Co-Founder & CEO, BioT; John Miller, VP Americas, BioT; and Alex Smith, Director of Regulatory Science, Hogan Lovells LLP, for the live webinar on Thursday, January 25, 2024, at 12pm EST (5pm GMT/UK).
For more information, or to register for this event, visit Cloud and Medical Device Cybersecurity: The FDA's 2023 Guidelines.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks

Share this article